Scientists at deCODE genetics, a subsidiary of Amgen, reveal today in Nature Genetics associations between bipolar disorder and rare loss-of-function variants in two genes.
Bipolar disorder is characterized by extreme mood swings,…
Scientists at deCODE genetics, a subsidiary of Amgen, reveal today in Nature Genetics associations between bipolar disorder and rare loss-of-function variants in two genes.
Bipolar disorder is characterized by extreme mood swings,…
The HZI team has developed an AI-powered computer model that, for the first time, reveals the aging process at the cellular level. As we age, our immune system ages as well. We become more susceptible to infections, vaccinations become less…
After every meal, the intestines perform an action called peristalsis – moving food through their hollow interiors with coordinated contractions and relaxations of the smooth muscle.
For more than a century, scientists have known…
ELRIG, a not-for-profit, volunteer-led organization for the drug discovery community, today announced the keynote speakers for Therapeutic Oligonucleotides 2025 taking place at the AstraZeneca R&D site in Gothenburg, Sweden from…
New research sheds light on one of the biggest questions in biology: where did complex life come from? The answer may lie with Asgard archaea, a group of ancient single-celled microbes that share surprising similarities with more complex…
A team of biologists at Queen Mary University of London has discovered that a neurohormone controlling appetite in humans has an ancient evolutionary origin, dating back over half a billion years. The findings, published in…
Among the many marvels of life is the cell’s ability to divide and thus enable organisms to grow and renew themselves. For this, the cell must duplicate its DNA – its genome – and segregate it equally into two new daughter…
The 3D structures were retrieved from three tools: I-TASSER, Robetta, and AlphaFold. Among these, the AlphaFold structure was selected ID (B2S3D0). The alignment graph from Alphafold represents the…
After a proof-of-concept preliminary version19, Rapid-CNS2 was run independently at two centers on fresh or cryopreserved tumor tissue (University Hospital Heidelberg, Germany and University of…